Liraglutide Powder
NDC Package 14403-0021-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Liraglutide powders is a medication used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. This formulation utilizes a powder delivery system. Marketed by Hybio Pharmaceutical Co., Ltd. (pingshan Factory), this product is identified by NDC 14403-0021.

Identification & Billing

NDC Package Code
14403-0021-2
Package Description
20 g in 1 BAG
Product Code
14403-0021
11-Digit Billing Format
14403002102

Clinical Specifications

Proprietary Name
Liraglutide
Non-Proprietary Name
Liraglutide
Substance Name
Liraglutide
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
Usage Information
This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Regulatory & Marketing

Labeler Name
Hybio Pharmaceutical Co., Ltd. (pingshan Factory)
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
12-19-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (14403-0021). Click a package code to view its specific billing and regulatory data.

14403-0021-1
10 g in 1 BAG
14403-0021-3
1 BOTTLE in 1 BAG / 20 g in 1 BOTTLE
14403-0021-4
100 mg in 1 BOTTLE
14403-0021-5
1 BAG in 1 BOTTLE / 1 g in 1 BAG
14403-0021-6
3 BAG in 1 BOTTLE / 1 g in 1 BAG
14403-0021-7
1 BAG in 1 BOTTLE / 5 g in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14403-0021-2 identifies a specific commercial package of 20 g in 1 bag of Liraglutide (UNFINISHED drug), a bulk ingredient labeled by Hybio Pharmaceutical Co., Ltd. (pingshan Factory). This powder is formulated for use and contains liraglutide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hybio Pharmaceutical Co., Ltd. (pingshan Factory) on December 19, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

How is this Hybio Pharmaceutical Co., Ltd. (pingshan Factory) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14403002102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
14403-0021-2
11-Digit CMS (5-4-2)
14403-0021-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.